Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis

Epidermal growth factor receptor (EGFR)-mutation-positive non-small cell lung cancer (NSCLC) is incurable, despite high rates of response to EGFR tyrosine kinase inhibitors (TKIs). We investigated receptor tyrosine kinases (RTKs), Src family kinases and focal adhesion kinase (FAK) as genetic modifie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Karachaliou, Niki, Chaib, Imane, Cardona, Andres Felipe, Berenguer, Jordi, Bracht, Jillian Wilhelmina Paulina, Yang, Jie, Cai, Xueting, Wang, Zhigang, Hu, Chunping, Drozdowskyj, Ana, Servat, Carles Codony, Servat, Jordi Codony, Ito, Masaoki, Attili, Ilaria, Aldeguer, Erika, Capitan, Ana Gimenez, Rodriguez, July, Rojas, Leonardo, Viteri, Santiago, Molina-Vila, Miguel Angel, Ou, Sai-Hong Ignatius, Okada, Morihito, Mok, Tony S., Bivona, Trever G., Ono, Mayumi, Cui, Jean, Cajal, Santiago Ramón y, Frias, Alex, Cao, Peng, Rosell, Rafael
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5925453/
https://ncbi.nlm.nih.gov/pubmed/29433983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.02.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados